Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
Status:
Recruiting
Trial end date:
2027-10-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine if a single dose of psilocybin administered with
motivational enhancement therapy (MET) can reduce heavy drinking in patients with an alcohol
use disorder (AUD).
Phase:
Phase 2
Details
Lead Sponsor:
University of Calgary
Collaborators:
Canadian Institutes of Health Research (CIHR) Johns Hopkins University University of Maryland